-
2 months ago | 
forbesindia.com | Kathakali Chanda |Kunal Purandare |Manisha dass
Forbes India 30 Under 30: Inside Yashasvi Jaiswal's incredible journey to the top On the cover of Forbes India's 30 under 30 issue is cricketer Yashasvi Jaiswal, who has risen the ranks with exceptional talent and grit. The rising star speaks to Forbes India's Kathakali Chanda and Kunal Purandare about his emotional beginnings, what he has learned from Rohit Sharma and Virat Kohli, and what his batting strategy has been
-
2 months ago | 
forbesindia.com | Naini Thaker |Manisha dass
'I was never really serious about music, until...': Hanumankind Forbes India Showstopper for 2024, Sooraj Cherukat, better known by his stage name Hanumankind, took big leaps last year with his English rap song, Big Dawgs. But music wasn't always part of the plan. Here, he speaks to Naini Thaker about going from corporate employee to rapper, his process of creating, and making music with no guidelines, no borders
-
Jan 20, 2025 | 
forbesindia.com | Divya J Shekhar |Manisha dass
The actor, who did a whopping 4 films in 2024, talks about internal conflicts, what money means to him, and the 'year of Rajkummar Rao'
-
Jan 20, 2025 | 
forbesindia.com | Naini Thaker |Manisha dass
Ananya Panday on family, relationships, and the year that changed her career In 2024, Ananya Panday managed to break out of the 'glam doll' image and surprise both critics and the audience with her strong performances in Call Me Bae and CTRL. In an unfiltered chat with Forbes India's Naini Thaker, she talks about being the only mainstream actress of her generation to embrace OTT, her family and relationships, body positivity, mental health and more
-
Nov 4, 2024 | 
forbesindia.com | Manu Balachandran |Manisha dass
In four years' time, Mahindra has turned around its fortunes to emerge as India's third-largest carmaker. It all started with the Thar in October 2020, followed by the success of the XUV 700, Scorpio N and now the Thar Roxx. In the one hour that it opened bookings for the Thar Roxx, Mahindra mopped up 176,000 bookings. Rajesh Jejurikar, the Executive Director and CEO (Auto and Farm Sector) at Mahindra & Mahindra, explains the phenomenal transformation at Mahindra
-
Oct 23, 2024 | 
forbesindia.com | Naini Thaker |Manisha dass
'I will return to Bollywood when...': Priyanka Chopra Jonas The actor-entrepreneur says she misses singing, dancing and speaking in Hindi, but is picky about her return to Hindi cinema. Find out about how her Hollywood experience has been different from Bollywood, her review of the upcoming 'Citadel: Honey Bunny' starring Varun Dhawan and Samantha Ruth Prabhu, her make-up routine and more
-
Aug 27, 2024 | 
forbesindia.com | Naandika Tripathi |Manisha dass
Bhavina Patel has been on crutches since she was diagnosed with polio at one year old. That didn't stop her creating history, by winning India's first silver medal in her category at the Tokyo Paralympics. As she sets her sights on the Paris Paralympics, the table tennis athlete, who is known for her smashes, speaks exclusively to Forbes India.
-
Aug 21, 2024 | 
forbesindia.com | Pankti Mehta Kadakia |Naandika Tripathi |Manisha dass
Kolkata rape-murder: Can this central law change the lives of doctors? The Supreme Court on Tuesday appealed to protesting doctors to resume work, in a suo moto hearing on Tuesday. Doctors, however, say they won't let up protests until a Central Protection Act is passed. What is this act, and why is it important? Find out in this explainer
-
May 9, 2024 | 
forbesindia.com | Kathakali Chanda |Manisha dass
'We didn't want to have any regrets 10 years on': Pat Cummins on ODI World Cup finals strategyThe Australian captain, now famous for silencing a home crowd at the World Cup finals in Ahmedabad, caught up with Forbes India at the launch of the New Balance store in Mumbai
-
May 3, 2024 | 
forbesindia.com | Anubhuti Matta |Manisha dass
Recent reports have raised concerns about rare side effects associated with AstraZeneca's Covid-19 vaccine, developed and manufactured as Covishield in India. For the first time, the pharma giant admitted that its vaccine can cause TTS—a severe condition resulting in low platelet count and blood clot formation. Experts say that while every vaccine has side effects, TTS is rare and was known to us before people were inoculated. Is there any reason to worry? Here's everything you should know
